Cargando…

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”

Detalles Bibliográficos
Autores principales:	Shaker, Marcus S., Phillips, Elizabeth, Blumenthal, Kimberly G., Abrams, Elissa M., Banerji, Aleena, Oppenheimer, John, Vander Leek, Timothy K., Mack, Douglas P., Wickner, Paige G., Singer, Alexander G., Khan, David A., Greenhawt, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Correspondence and Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181594/ https://www.ncbi.nlm.nih.gov/pubmed/34112481 http://dx.doi.org/10.1016/j.jaip.2021.03.016

Ejemplares similares

The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis
por: Shaker, Marcus, et al.
Publicado: (2021)

Reply to “PEG skin testing for COVID-19 allergy”
por: Banerji, Aleena, et al.
Publicado: (2021)

The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Estimation of Health and Economic Benefits of a Small Automatic External Defibrillator for Rapid Treatment of Sudden Cardiac Arrest (SMART): A Cost-Effectiveness Analysis
por: Shaker, Marcus S., et al.
Publicado: (2022)

What the COVID-19 Pandemic Can Teach Us About Resource Stewardship and Quality in Health Care
por: Abrams, Elissa M., et al.
Publicado: (2021)

Reply
por: Villa, E, et al.
Publicado: (2001)

In reply:
por: Starčević Čizmarević, Nada, et al.
Publicado: (2021)

Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada
por: Abrams, Elissa M., et al.
Publicado: (2021)

The Authors’ Reply
por: Mallik, Sarmila, et al.
Publicado: (2012)

The authors’ reply
por: El-Kannishy, Ghada M.
Publicado: (2018)

The authors’ reply
por: Kim, Hyo Shik, et al.
Publicado: (2017)

Authors’ reply
por: Myrtennäs, Kerstin, et al.
Publicado: (2017)

The author’s reply
por: Park, Chun Soo
Publicado: (2022)

The author’s reply
por: Park, Hyung Joo
Publicado: (2022)

Reply to the Letter “Create Guidelines for Characterization of Venom Peptides” from Dr. Volker Herzig
por: Gomez, Marcus Vinicius
Publicado: (2016)

mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
por: Banerji, Aleena, et al.
Publicado: (2021)

Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times
por: Shaker, Marcus S., et al.
Publicado: (2020)

Reply to the Comment of G. Feulner
por: Weber, Werner
Publicado: (2011)

In Reply to: Fine Needle Aspiration
por: Ehsanbakhsh, Ali-Reza, et al.
Publicado: (2014)

Reply to the Comment by Littlechild and Isupov
por: Willetts, Andrew, et al.
Publicado: (2017)

The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
por: Abrams, Elissa M., et al.
Publicado: (2020)

Reply to “The Carotid Sinus as a Viscometer”
por: Lee, Ui Yun, et al.
Publicado: (2020)

Reply to ‘Management of noncompaction requires optimisation’
por: Gurunathan, Sothinathan, et al.
Publicado: (2019)

Author's Reply
por: Stephan, Farid E, et al.
Publicado: (2016)

The Slopes Remain the Same: Reply to Wolfe (2016)
por: Kristjánsson, Árni
Publicado: (2016)

The Paradox of Ingestion of Dietary Cholesterol in “Vegans”—Reply
por: Clarys, Peter, et al.
Publicado: (2017)

Reply to “Dyslexia: Still Not a Neurodevelopmental Disorder”
por: Fraga González, Gorka, et al.
Publicado: (2019)

A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies
por: Shaker, Marcus, et al.
Publicado: (2021)

School Attendance, Asthma Risk, and COVID-19 in Children
por: Abrams, Elissa M., et al.
Publicado: (2021)

COVID-19 and the importance of effective risk communication with children
por: Abrams, Elissa M, et al.
Publicado: (2022)

Reply to commentary on costs of diabetes and its complications in Poland
por: Leśniowska, Joanna
Publicado: (2014)

Correction to Figures: A Reply to Hwang and Peli (2014)
por: Gao, Zhongpai
Publicado: (2017)

Maximum Entropy Theory of Ecology: A Reply to Harte
por: Favretti, Marco
Publicado: (2018)

In reply to Unopposed Estrogen and Endometrial Cancer: Association or Causation?
por: Trkulja, Vladimir, et al.
Publicado: (2019)

Reply to Comment “Assessing Porous Media Permeability in Non-Darcy Flow: A Re-Evaluation Based on the Forchheimer Equation”
por: Castro, A. P. G., et al.
Publicado: (2020)

Reply to Çınar et al. Comment on “Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874”
por: Caruntu, Ana, et al.
Publicado: (2022)

COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach
por: Banerji, Aleena, et al.
Publicado: (2021)

First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
por: Wolfson, Anna R., et al.
Publicado: (2021)

Reply to “Missing Skeletal Muscle Metastases of Papillary Thyroid Carcinoma”
por: Hitu, Liviu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3eb3s1qvv7n3u0jl199ora2kqj